Nutrition services during prostate cancer androgen deprivation therapy

被引:2
|
作者
Baguley, Brenton [1 ,4 ]
Smith-Gillis, Caity [2 ]
Porter, Judi [1 ]
Kiss, Nicole [1 ]
Ugalde, Anna [3 ]
机构
[1] Deakin Univ, Inst Phys Act & Nutr, Geelong, Vic, Australia
[2] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Vic, Australia
[3] Deakin Univ, Inst Hlth Transformat, Burwood, Vic, Australia
[4] Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic 3125, Australia
关键词
prostate; quality of life; supportive care; survivorship; QUALITY-OF-LIFE; MEN; SOCIETY; HEALTH; RISK; DIET; GUIDELINES; DIAGNOSIS; MORTALITY; SURVIVORS;
D O I
10.1136/spcare-2023-004304
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectiveDietary interventions are effective strategies to mitigate multiple side effects from androgen deprivation therapy (ADT) in prostate cancer, however the perception of, and access to, nutrition services is relatively unknown. MethodsA qualitative study using semistructured, audio recorded interviews was conducted in men with prostate cancer treated with ADT for & GE;3 months. Interviews explored (1) side effects of ADT and drivers for dietary change, (2) accessibility, barriers, facilitators and use of nutrition services and (3) the preferences for nutrition service delivery. Data were coded using interpretative descriptive techniques of textual interview data, and systematically summarised to generate thematical patterns, using NVivo software. ResultsInterviews were completed of 20 men with prostate cancer treated with ADT (25.5 & PLUSMN;20.1 months). Thematic analysis revealed four overarching themes-(1) the changes from ADT: men revealed that weight gain, loss of muscle and strength from ADT were daily struggles that negatively impact body image and components of masculinity reduced; (2) strategies to take control: several dietary changes were trialled and restrictive in foods and nutrients. Barriers to accessing nutrition specialists were the cost for the service and absence of a clear referral pathway; (3) importance of nutrition knowledge: demand for specialised nutrition services with knowledge in addressing side effects from ADT; (4) diverse patients need diverse nutrition support: that includes peer or partner support, and technology supported nutrition content. ConclusionEvidence-based nutrition services are an unmet need for men treated with ADT. Future work is required to develop services that can be readily available and accessible to improve prostate cancer survivorship care.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] The perception of and access to nutrition services for men with prostate cancer treated with androgen deprivation therapy
    Baguley, Brenton
    Smith, Caity
    Ugalde, Anna
    Kiss, Nicole
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 207 - 207
  • [2] Osteoporosis during androgen deprivation therapy for prostate cancer
    Smith, MR
    UROLOGY, 2002, 60 (3A) : 79 - 85
  • [3] Androgen Deprivation Therapy for Prostate Cancer
    Pagliarulo, Vincenzo
    MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 1 - 30
  • [4] Androgen deprivation therapy for prostate cancer
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (10): : E567 - E567
  • [5] Androgen deprivation therapy for prostate cancer
    Sharifi, N
    Gulley, JL
    Dahut, WL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (02): : 238 - 244
  • [6] Androgen deprivation therapy for prostate cancer
    Bahnson, Robert
    JOURNAL OF UROLOGY, 2007, 178 (04): : 1148 - 1148
  • [7] Androgen deprivation therapy for prostate cancer
    Singer, Eric A.
    Golijanin, Dragan J.
    Miyamoto, Hiroshi
    Messing, Edward M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (02) : 211 - 228
  • [8] Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Saad, Fred
    Egerdie, Blair
    Sieber, Paul R.
    Tammela, Teuvo L. J.
    Ke, Chunlei
    Leder, Benjamin Z.
    Goessl, Carsten
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3271 - 3276
  • [9] Progressive osteoporosis during androgen deprivation therapy for prostate cancer
    Daniell, HW
    Dunn, SR
    Ferguson, DW
    Lomas, G
    Niazi, Z
    Stratte, PT
    JOURNAL OF UROLOGY, 2000, 163 (01): : 181 - 186
  • [10] Osteoporosis during androgen deprivation therapy for prostate cancer - Discussion
    George, DJ
    Smith, MR
    Sartor, O
    McLeod, DG
    Carroll, PR
    UROLOGY, 2002, 60 (3A) : 86 - 86